Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease

To evaluate the safety, efficacy, and outcomes of endovascular strategies for protection of the contralateral CIA in patients with symptomatic unilateral CIA occlusive disease

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Iliac Artery Disease

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Symptomatic patients (Rutherford category 3- 5) due to Unilateral common iliac artery occlusive disease.

with or without combined iliac or femoropopliteal or infrapopliteal lesions.

Asymptomatic Contralateral limb.

Patent at least one run-off vessel

Exclusion criteria

Distal aorta lesion

contralateral CIA occlusion

Previous endovascular or surgical procedures for the same lesion

Hypersensitivity to contrast material

Presence of aortic or iliac aneurysms

Patients with unsalvageable limb

Non atherosclerotic lesions

Treatment and study plan

Common iliac artery stenting

Procedure

Stenting of common iliac artery by balloon mounted stent

Primary outcomes

Primary patency of both common iliac arteries

Time frame: 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

abdelrahman eltokhey

CONTACT

[email protected]

01003830585

mahmoud ismail

CONTACT

[email protected]

0106228283

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2027
First posted: Jun 10, 2025
Registry last updated: Jun 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting